New anti-wrinkle drug challenges Botox Health24.com J&J expects to seek US approval next year for an anti-wrinkle drug that could break Botox's near monopoly, an 85% market share. The J&J product could be available in the United States in 2015 and overseas a few years later, the company said. Two ... |
No comments:
Post a Comment